Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review [PDF]
The incidence of in situ melanoma (MIS) has increased over the last decades. The mainstay of treatment for MIS, including lentigo maligna (LM), is complete surgical excision with clear margins (0.5 to 1.0 cm). Nevertheless, MIS lesions often affect elderly patients with comorbidities and involve large lesions in cosmetically sensitive areas, which ...
Diego Soto-García +2 more
exaly +5 more sources
Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids [PDF]
The use of topical and intralesional immunotherapy in the treatment of cutaneous malignant neoplasia in sensitive areas such as the lips and eyelids is discussed. Surgery may not be feasible or may result in deformities in these areas, making alternative
Angeles Florez, Cecilia Bujan Bonino
exaly +3 more sources
Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases [PDF]
Warts are common benign skin tumors caused by human papilloma viruses. Recalcitrant facial warts tend to be cosmetically embarrassing to patients and difficult to treat for doctors.
Al Mutasim Al-Qassabi +1 more
doaj +2 more sources
Comparative Analysis of Intralesional Immunotherapy and Conventional Treatments for Non-Genital Warts: A Systematic Review and Network Meta-Analysis [PDF]
Introduction: Warts, benign skin growths caused by various human papillomavirus strains, are categorized as genital and non-genital. Non-genital warts often lack noticeable symptoms but can lead to psychological distress due to factors like ...
Amr Molla +9 more
doaj +2 more sources
Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations. [PDF]
A panel of 18 dermatologists participated in a three‐round Delphi‐based consensus process to generate a standardized framework for the diagnosis and management of alopecia areata (AA) in Asia Pacific. Recommendations focus on practicality and clinical relevance within the regional context.
Sinclair R +17 more
europepmc +2 more sources
Pati Aji Achdiat,1 Narizka Civiadenta Antariksa,1 Rasmia Rowawi,1 Oki Suwarsa,1 Yudi Mulyana Hidayat,2 Reiva Farah Dwiyana,1 Hendra Gunawan,1 Reti Hindritiani1 1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran-Dr ...
Pati Aji Achdiat +2 more
exaly +2 more sources
S3 guideline diagnostics and therapy in alopecia areata - Part 2: Therapy, psychosocial and cosmetic support. [PDF]
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Blume-Peytavi U +13 more
europepmc +2 more sources
Intralesional Vitamin D in Dermatology: An Evidence-Based Review of Utility [PDF]
Vitamin D has been used in a gamut of medical conditions, including dermatology. Intralesional Vitamin D, however, is not a common therapeutic option in dermatological disorders.
Subuhi Kaul, Piyush Kumar, Anupam Das
doaj +2 more sources
From Scalpel to Syringe: Intralesional Interleukin-2-Based Therapy is Effective for Locally Advanced Periocular Cutaneous Squamous Cell Carcinoma [PDF]
Introduction Cutaneous squamous cell carcinoma (cSCC) is a common eyelid malignancy that is typically treated by surgical excision. Locally destructive periocular cSCC may not be amenable to surgery in cases where extensive resection would result in ...
Sorayya Seddigh +5 more
doaj +2 more sources
A comparative study of the therapeutic efficacy of various intralesional immunotherapies in extragenital cutaneous warts [PDF]
Background: Cutaneous warts are caused by human papilloma virus (HPV). Most of the current removal modalities are ablative which is associated with recurrence and scarring at the site.
Nimisha Kabra, Rajesh Sinha, U.K Pallavi
doaj +2 more sources

